Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.

Hum Mol Genet · 2016 · PMC5886039 · PMID 28171547

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP = 0.09so close (0.05 < p ≤ 0.1)

Differences in residual CFTR-mediated current across the rs7512462 genotypes in the cultures with vehicle only (DMSO, n = 10) did not reach statistical significance ( P = 0.09, -0.17 μA/cm 2 ΔI eq -forskolin per C protective allele, Fig. 3B , red).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.